Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT02414750
Status:
TERMINATED
Last Update Posted:
2022-11-30
First Post:
2015-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Sponsor:
Netherlands Working Group on Immunotherapy of Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
M14REP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None